A family of autosomal dominant hypocalcemia with a positive correlation between serum calcium and magnesium:: Identification of a novel gain of function mutation (Ser820Phe) in the calcium-sensing receptor

被引:20
作者
Nagase, T
Murakami, T
Tsukada, T
Kitamura, R
Chikatsu, N
Takeo, H
Takata, N
Yasuda, H
Fukumoto, S
Tanaka, Y
Nagata, N
Yamaguchi, K
Akatsu, T
Yamamoto, M
机构
[1] Niigata Univ Hlth & Welf, Sch Hlth Sci, Dept Hlth & Nutr, Niigata 9503198, Japan
[2] Natl Canc Ctr, Res Inst, Div Growth Factor, Tokyo 1040045, Japan
[3] Natl Def Med Coll, Dept Internal Med 3, Saitama 3598513, Japan
[4] Natl Def Med Coll, Dept Gen Med, Saitama 3598513, Japan
[5] Univ Tokyo, Branch Hosp, Tokyo 1128868, Japan
[6] Self Def Forces Cent Hosp, Dept Internal Med, Tokyo 1548532, Japan
关键词
D O I
10.1210/jc.87.6.2681
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To date about 20 activating mutations in the calcium-sensing receptor (CaR) gene have been identified to cause autosomal dominant hypocalcemia (ADH) or sporadic hypoparathyroid. ism. We report a novel activating mutation in the CaR gene in a Japanese family with ADH. The proband, a 15-yr-old boy, and 5 other patients in 3 generations were asymptomatic, except for the proband's grandmother who had a history of seizures. They showed mild hypocalcemia (1.68-1.98 mmol/liter) with normal urinary calcium excretion and low normal serum PTH levels. Their serum magnesium concentrations were below normal in 3 adults and within the normal range in 3 teenagers. There was a significant positive correlation (r = 0.90; P < 0.05) between the serum calcium and magnesium concentrations of 6 affected members. Nucleotide sequencing revealed that the proband had a known polymorphism (Gly(990) Arg) and a novel heterozygous mutation substituting phenylalanine for serine at codon 820 (Ser(820)Phe) in the sixth transmembrane helix of the CaR. In other family members, the Ser(820)Phe mutation cosegregated with hypocalcemia. The mutation was not detected in 50 control subjects. The Gly(990)Arg polymorphism was observed in 8 of 9 family members with or without hypocalcemia and in 36 of 50 controls. The sensitivity of the Ser(820)Phe mutant CaR to calcium was assessed using transiently transfected HEK293 cells and measuring the increases in intracellular Ca2+ concentrations in response to the changes in extracellular Ca2+. The concentration-response curve of the mutant receptor was left-shifted, and its EC50 (2.5 mm) was significantly (P < 0.05) lower than that of the wildtype CaR (3.3 mM). We conclude that the Ser(820)Phe mutation in the CaR caused ADH in this family. The positive correlation between serum calcium and magnesium levels observed in this family may support the concept that renal CaR acts as a magnesium sensor as well as a calcium sensor.
引用
收藏
页码:2681 / 2687
页数:7
相关论文
共 30 条
[11]   A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations [J].
Cole, DEC ;
Peltekova, VD ;
Rubin, LA ;
Hawker, GA ;
Vieth, R ;
Liew, CC ;
Hwang, DM ;
Evrovski, J ;
Hendy, GN .
LANCET, 1999, 353 (9147) :112-115
[12]   Three novel activating mutations in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia [J].
Conley, YP ;
Finegold, DN ;
Peters, DG ;
Cook, JS ;
Oppenheim, DS ;
Ferrell, RE .
MOLECULAR GENETICS AND METABOLISM, 2000, 71 (04) :591-598
[13]   Sporadic hypoparathyroidism caused by de novo gain-of-function mutations of the Ca2+-sensing receptor [J].
DeLuca, F ;
Ray, K ;
Mancilla, EE ;
Fan, GF ;
Winer, KK ;
Gore, P ;
Spiegel, AM ;
Baron, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (08) :2710-2715
[14]   MOLECULAR-CLONING AND FUNCTIONAL EXPRESSION OF HUMAN PARATHYROID CALCIUM RECEPTOR CDNAS [J].
GARRETT, JE ;
CAPUANO, IV ;
HAMMERLAND, LG ;
HUNG, BCP ;
BROWN, EM ;
HEBERT, SC ;
NEMETH, EF ;
FULLER, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (21) :12919-12925
[15]   Monoclonal antibodies against synthetic peptides corresponding to the extracellular domain of the human Ca2+ receptor: Characterization and use in studying concanavalin A inhibition [J].
Goldsmith, PK ;
Fan, GF ;
Miller, JL ;
Rogers, KV ;
Spiegel, AM .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (11) :1780-1788
[16]   Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains [J].
Heath, H ;
Odelberg, S ;
Jackson, CE ;
Teh, BT ;
Hayward, N ;
Larsson, C ;
Buist, NRM ;
Krapcho, KJ ;
Hung, BC ;
Capuano, IV ;
Garrett, JE ;
Leppert, MF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (04) :1312-1317
[17]  
Hendy GN, 2000, HUM MUTAT, V16, P281, DOI 10.1002/1098-1004(200010)16:4<281::AID-HUMU1>3.0.CO
[18]  
2-A
[19]   The effect of calcium-sensing receptor gene polymorphisms on serum calcium levels: A familial hypocalciuric hypercalcemia family without mutation in the calcium-sensing receptor gene [J].
Kanazawa, H ;
Tanaka, H ;
Kodama, S ;
Moriwake, T ;
Kobayashi, M ;
Seino, Y .
ENDOCRINE JOURNAL, 2000, 47 (01) :29-35
[20]   A Ca2+-sensing receptor mutation causes hypoparathyroidism by increasing receptor sensitivity to Ca2+ and maximal signal transduction [J].
Mancilla, EE ;
DeLuca, F ;
Ray, K ;
Winer, KK ;
Fan, GF ;
Baron, J .
PEDIATRIC RESEARCH, 1997, 42 (04) :443-447